These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31169593)

  • 1. Second generation antihistamines: an update.
    Sánchez-Borges M; Ansotegui IJ
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):358-364. PubMed ID: 31169593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of cetirizine in the treatment of allergic rhinitis.
    Zhang L; Cheng L; Hong J
    Pharmacology; 2013; 92(1-2):14-25. PubMed ID: 23867423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
    Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
    Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
    Van Cauwenberge P; De Belder T; Sys L
    Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
    Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
    Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of anti-allergic drugs in children.
    Suárez-Castañón C; Modroño-Riaño G; Solís-Sánchez G
    Allergol Immunopathol (Madr); 2017; 45(5):506-507. PubMed ID: 28161282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic rhinitis during pregnancy.
    Prescrire Int; 2016 Apr; 25(170):101-2, 104. PubMed ID: 27186624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.
    Wolthers OD
    Biomed Res Int; 2013; 2013():626837. PubMed ID: 23956994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
    Abelson MB; Gomes PJ
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):453-61. PubMed ID: 18433347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
    Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
    Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
    González-Núñez V; Bachert C; Mullol J
    Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistamines: ABC for the pediatricians.
    Parisi GF; Licari A; Papale M; Manti S; Salpietro C; Marseglia GL; Leonardi S
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():34-36. PubMed ID: 32017222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
    Church MK; Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos NG; Rodriguez Del Rio P;
    Expert Rev Clin Immunol; 2023; 19(7):813-820. PubMed ID: 37191185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-annual and seasonal allergic conjunctivitis treatment: comparison of two therapeutic protocols].
    Lazreg S; Colin J; Renault D; Hartani D
    J Fr Ophtalmol; 2008 Dec; 31(10):961-7. PubMed ID: 19107071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.